The prognostic value of stress echocardiography among patients with coronary artery disease
Stress echocardiography (SE) was first proposed as a non invasive clinical tool for coronary artery disease diagnosis and risk stratification in 1979. Since then, there have been over 7,000 publications validating the use of SE in the management of patients with coronary disease, valve disease, heart failure and cardiomyopathy. This article will focus on the prognostic utility of SE among patients with ischaemic heart disease. The test is especially popular as it is very safe and cost effective.
The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.